PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 8102559-15 1993 TPA-activated B-CLL cells showed a 1.2- to 13-fold increased expression of the adhesion molecules intercellular adhesion molecule-1 (ICAM-1), lymphocyte function-associated antigen (LFA)-1, and LFA-3, whereas expression of HLA class II molecules increased up to 5 times. Tetradecanoylphorbol Acetate 0-3 CD58 molecule Homo sapiens 194-199 9099936-10 1996 Both spontaneous and up-regulated expression of ICAM-1, LFA-3 and VCAM-1 by IFN-gamma, IL-1beta or 12-o-tetradecanoyl phorbol 13-acetate (TPA) were markedly suppressed by clarithromycin in a dose-dependent manner at concentrations between 0.1 and 10 microg/ml. Tetradecanoylphorbol Acetate 99-136 CD58 molecule Homo sapiens 56-61 9099936-10 1996 Both spontaneous and up-regulated expression of ICAM-1, LFA-3 and VCAM-1 by IFN-gamma, IL-1beta or 12-o-tetradecanoyl phorbol 13-acetate (TPA) were markedly suppressed by clarithromycin in a dose-dependent manner at concentrations between 0.1 and 10 microg/ml. Tetradecanoylphorbol Acetate 138-141 CD58 molecule Homo sapiens 56-61 2899354-7 1988 Antibody L180/1, specific for the T11 (CD2) target structure (T11TS) on SE, homologous to the human CD2 ligand LFA-3, abolished the response to SENAGO alone or when combined with PEG or TPA. Tetradecanoylphorbol Acetate 186-189 CD58 molecule Homo sapiens 111-116